Oakville, Canada

Radoslaw Laufer

This inventor holds 30 USPTO granted patents and 7 published patent applications, plus 21 CIPO patents and 7 EPO patents. Top assignees: University Health Network, Osi Pharmaceuticals, Inc.. Active years: 2008-2021.

USPTO Granted Patents = 30 

% Patents Active = 70.0


 

Average Co-Inventor Count = 7.8

ph-index = 8

Forward Citations = 172(Granted Patents)


Location History:

  • Holtsville, NY (US) (2009)
  • Farmingdale, NY (US) (2008 - 2010)
  • Ontario, CA (2010 - 2014)
  • Ontario, CA (US) (2014)
  • Oakville, CA (2012 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: The Innovative Journey of Radoslaw Laufer

Introduction:

Radoslaw Laufer, a visionary inventor hailing from Oakville, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Radoslaw Laufer's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and smart home systems, showcasing his commitment to revolutionizing everyday life through technology.

Career Highlights:

With over two decades of experience in the tech industry, Radoslaw Laufer has held key positions in renowned tech companies, leading research and development teams to create innovative solutions that have garnered international acclaim.

Collaborations:

Throughout his career, Radoslaw Laufer has collaborated with top research institutions and universities to push the boundaries of technological innovation. His partnerships have resulted in pioneering projects that have set new standards in the industry.

Conclusion:

In conclusion, Radoslaw Laufer's passion for innovation and his relentless drive to push the limits of technology have solidified his reputation as a trailblazing inventor in Oakville, CA, and beyond. His work continues to inspire future generations of inventors to think boldly and create the impossible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…